His primary scientific interests are in Antibody, Virology, Epitope, Monoclonal antibody and Immunology. His Antibody research incorporates themes from Mutation, Antigen and AIDSVAX. His Virology research integrates issues from Peptide sequence, Immune system and B cell.
S. Munir Alam combines subjects such as Central tolerance, Immune tolerance and Molecular biology with his study of Monoclonal antibody. In his research on the topic of Immunology, HIV Antigens and Immunization is strongly related with HIV vaccine. S. Munir Alam has included themes like Protein structure and Glycan in his Neutralization study.
Antibody, Virology, Epitope, Immunology and Monoclonal antibody are his primary areas of study. His research on Antibody focuses in particular on Neutralization. The Virology study combines topics in areas such as Immunogen, Gp41 and B cell.
His studies in Epitope integrate themes in fields like Antibody-dependent cell-mediated cytotoxicity, Immunogenicity, Molecular biology, Peptide sequence and Glycan. His Monoclonal antibody study also includes
His scientific interests lie mostly in Antibody, Virology, Vaccination, Immunology and Severe acute respiratory syndrome coronavirus 2. S. Munir Alam performs multidisciplinary study in the fields of Antibody and Naive B cell via his papers. Much of his study explores Virology relationship to Glycan.
His work is dedicated to discovering how Vaccination, Immunization are connected with Titer, HIV vaccine and Transmission and other disciplines. His biological study spans a wide range of topics, including Typhoid fever and Modified vaccinia Ankara. His Neutralizing antibody research is multidisciplinary, incorporating elements of Epitope, Glycosylation, Neutralization and Immunogenicity.
S. Munir Alam spends much of his time researching Protein domain, 2019-20 coronavirus outbreak, Cold sensitivity, Cell biology and Severe acute respiratory syndrome coronavirus 2. His research in Protein domain intersects with topics in Biophysics, Viral entry, Plasma protein binding and Gp41. Ectodomain, Protein stability and Spike are fields of study that intersect with his 2019-20 coronavirus outbreak research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Barton F. Haynes;Judith Fleming;E. William St. Clair;Herman Katinger.
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao.
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang;Gilad Ofek;Leo Laub;Mark K. Louder.
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
Mattia Bonsignori;Kwan Ki Hwang;Xi Chen;Chun Yen Tsao.
Journal of Virology (2011)
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp.
Science Translational Medicine (2014)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan.
The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes
S. Munir Alam;Mildred McAdams;David Boren;Michael Rak.
Journal of Immunology (2007)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam.
Proceedings of the National Academy of Sciences of the United States of America (2013)
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group M consensus envelope glycoprotein
Feng Gao;Eric A. Weaver;Zhongjing Lu;Yingying Li.
Journal of Virology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: